Video Experimental Relacionado
Updated: May 10, 2026
06:51
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
La glutamina apoya el crecimiento del cáncer de páncreas a través de una vía metabólica regulada por KRAS
Jaekyoung Son1, Costas A Lyssiotis, Haoqiang Ying
1Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Nature
|March 29, 2013
Resumen
Las células de cáncer de páncreas utilizan una vía metabólica única que involucra glutamina, aspartato y oxaloacetato para el crecimiento. La inhibición de esta vía detiene la progresión tumoral y ofrece nuevas estrategias terapéuticas potenciales para el adenocarcinoma ductal pancreático.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Oncología Oncología.
- Las vías metabólicas.
Sus antecedentes:
- Las células cancerosas exhiben distintas dependencias metabólicas en comparación con las células normales.
- La glutamina es un aminoácido clave que alimenta los procesos anabólicos en muchos tumores.
- Comprender el metabolismo de la glutamina en el cáncer es crucial para desarrollar terapias dirigidas.
Objetivo del estudio:
- Identificar y caracterizar una nueva vía metabólica de la glutamina en el adenocarcinoma ductal pancreático (PDAC).
- Investigar el papel de esta vía en el crecimiento y la supervivencia de tumores PDAC.
- Para explorar el potencial terapéutico de dirigirse a este metabolismo no canónico de la glutamina.
Principales métodos:
- Utilizaron líneas celulares de adenocarcinoma ductal pancreático humano (PDAC).
- Investigó el metabolismo de la glutamina a través de ensayos enzimáticos y la inhibición genética.
- Evaluar el crecimiento tumoral in vitro e in vivo después de la manipulación de la vía.
- Se analizó el papel del KRAS oncogénico en la regulación de esta reprogramación metabólica.
Principales resultados:
- Se identificó una vía no canónica por la que las células PDAC convierten el aspartato derivado de la glutamina en oxaloacetato en el citoplasma.
- Esta vía aumenta la relación NADPH/NADP ((+), manteniendo el estado redox celular y reduciendo las especies reactivas de oxígeno.
- La privación de glutamina o la inhibición genética de las enzimas de la vía aumentaron el estrés oxidativo y redujeron el glutatión.
- La eliminación de enzimas clave suprimió el crecimiento de PDAC in vitro e in vivo.
- El KRAS oncogénico media esta reprogramación metabólica a través del control transcripcional de las enzimas.
Conclusiones:
- Las células PDAC dependen de una vía citoplasmática única para el metabolismo de la glutamina, distinta de la ruta mitocondrial canónica.
- Esta vía es esencial para el crecimiento de PDAC, el equilibrio redox y la supervivencia.
- Dirigirse a esta vulnerabilidad metabólica mediada por KRAS presenta una estrategia terapéutica prometedora para el cáncer de páncreas.
Más Videos Relacionados
Videos de Conceptos Relacionados
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...